Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Cresco Labs a Risky Buy?


Cresco Labs (OTC: CRLBF) is looking to be one of the larger survivors in a cannabis industry that is going through a tumultuous phase.

The Chicago company's stock is down roughly 50% from where it was a year ago, and it has yet to turn a profit. However, Cresco saw significant revenue growth last quarter. With $68.6 million in cash, can the company last until it starts making money? 

IMAGE SOURCE: GETTY IMAGES

Continue reading


Source Fool.com

Like: 0
Share

Comments